Radiation boosts immunotherapy in advanced cancer trial
NCT ID NCT07381231
First seen Feb 02, 2026 · Last updated May 21, 2026 · Updated 19 times
Summary
This study tests whether adding a special type of high-dose radiation (adaptive pulse radiotherapy) to standard immunotherapy can help control advanced solid tumors better than immunotherapy alone. About 35 adults with various cancers who are already receiving or planning to receive immunotherapy will get 2-3 radiation sessions alongside their usual treatment. Researchers will monitor tumor response, side effects, immune system changes, and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Samsung medical center
RECRUITINGSeoul, 06351, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.